178 related articles for article (PubMed ID: 26906432)
1. HABP2 Gene Mutations Do Not Cause Familial or Sporadic Non-Medullary Thyroid Cancer in a Highly Inbred Middle Eastern Population.
Alzahrani AS; Murugan AK; Qasem E; Al-Hindi H
Thyroid; 2016 May; 26(5):667-71. PubMed ID: 26906432
[TBL] [Abstract][Full Text] [Related]
2. Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review.
Colombo C; Muzza M; Proverbio MC; Ercoli G; Perrino M; Cirello V; Vicentini L; Ferrero S; Fugazzola L
Clin Endocrinol (Oxf); 2017 Jun; 86(6):837-844. PubMed ID: 28222214
[TBL] [Abstract][Full Text] [Related]
3. HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series.
Cantara S; Marzocchi C; Castagna MG; Pacini F
J Endocrinol Invest; 2017 May; 40(5):557-560. PubMed ID: 27873212
[TBL] [Abstract][Full Text] [Related]
4. The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer.
Sahasrabudhe R; Stultz J; Williamson J; Lott P; Estrada A; Bohorquez M; Palles C; Polanco-Echeverry G; Jaeger E; Martin L; Magdalena Echeverry M; Tomlinson I; Carvajal-Carmona LG;
J Clin Endocrinol Metab; 2016 Mar; 10(3):1098-1103. PubMed ID: 26691890
[TBL] [Abstract][Full Text] [Related]
5. HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.
Weeks AL; Wilson SG; Ward L; Goldblatt J; Hui J; Walsh JP
BMC Med Genet; 2016 Aug; 17(1):60. PubMed ID: 27530615
[TBL] [Abstract][Full Text] [Related]
6. The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in Hispanics.
Bohórquez ME; Estrada AP; Stultz J; Sahasrabudhe R; Williamson J; Lott P; Duque CS; Donado J; Mateus G; Bolaños F; Vélez A; Echeverry M; Carvajal-Carmona LG
Endocr Connect; 2016 May; 5(3):123-7. PubMed ID: 27097599
[TBL] [Abstract][Full Text] [Related]
7. The p.G534E variant of
Kowalik A; Gąsior-Perczak D; Gromek M; Siołek M; Walczyk A; Pałyga I; Chłopek M; Kopczyński J; Mężyk R; Kowalska A; Góźdź S
Oncotarget; 2017 Aug; 8(35):58304-58308. PubMed ID: 28938557
[TBL] [Abstract][Full Text] [Related]
8. HABP2 G534E Variant in Papillary Thyroid Carcinoma.
Tomsic J; Fultz R; Liyanarachchi S; He H; Senter L; de la Chapelle A
PLoS One; 2016; 11(1):e0146315. PubMed ID: 26745718
[TBL] [Abstract][Full Text] [Related]
9. Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.
Gara SK; Jia L; Merino MJ; Agarwal SK; Zhang L; Cam M; Patel D; Kebebew E
N Engl J Med; 2015 Jul; 373(5):448-55. PubMed ID: 26222560
[TBL] [Abstract][Full Text] [Related]
10. Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population.
de Randamie R; Martos-Moreno GÁ; Lumbreras C; Chueca M; Donnay S; Luque M; Regojo RM; Mendiola M; Hardisson D; Argente J; Moreno JC
Horm Res Paediatr; 2018; 89(6):397-407. PubMed ID: 29895015
[TBL] [Abstract][Full Text] [Related]
11. HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
Zhang T; Xing M
J Natl Cancer Inst; 2016 Jun; 108(6):djv415. PubMed ID: 26832773
[TBL] [Abstract][Full Text] [Related]
12. HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.
Pinheiro M; Drigo SA; Tonhosolo R; Andrade SCS; Marchi FA; Jurisica I; Kowalski LP; Achatz MI; Rogatto SR
Oncotarget; 2017 Jun; 8(25):40896-40905. PubMed ID: 28402931
[TBL] [Abstract][Full Text] [Related]
13. Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls.
Kern B; Coppin L; Romanet P; Crépin M; Szuster I; Renaud F; Leteurtre E; Frénois F; Wemeau JL; Carnaille B; Cardot-Bauters C; Do Cao C; Pigny P
Eur J Med Genet; 2017 Mar; 60(3):178-184. PubMed ID: 28089742
[TBL] [Abstract][Full Text] [Related]
14. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
[TBL] [Abstract][Full Text] [Related]
15. G534E Variant in HABP2 and Nonmedullary Thyroid Cancer.
Ruiz-Ferrer M; Fernández RM; Navarro E; Antiñolo G; Borrego S
Thyroid; 2016 Jul; 26(7):987-8. PubMed ID: 27245704
[No Abstract] [Full Text] [Related]
16. Genetic susceptibility to hereditary non-medullary thyroid cancer.
Kamani T; Charkhchi P; Zahedi A; Akbari MR
Hered Cancer Clin Pract; 2022 Mar; 20(1):9. PubMed ID: 35255942
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor interacting protein mutations seem not to associate with familial non-medullary thyroid cancer.
Raitila A; Georgitsi M; Bonora E; Vargiolu M; Tuppurainen K; Mäkinen MJ; Vierimaa O; Salmela PI; Launonen V; Vahteristo P; Aaltonen LA; Romeo G; Karhu A
J Endocrinol Invest; 2009 May; 32(5):426-9. PubMed ID: 19794292
[TBL] [Abstract][Full Text] [Related]
18. Whole Genome Sequencing Prioritizes
Srivastava A; Giangiobbe S; Skopelitou D; Miao B; Paramasivam N; Diquigiovanni C; Bonora E; Hemminki K; Försti A; Bandapalli OR
Front Endocrinol (Lausanne); 2021; 12():600682. PubMed ID: 33692755
[TBL] [Abstract][Full Text] [Related]
19. Identification of Rare Variants Predisposing to Thyroid Cancer.
Wang Y; Liyanarachchi S; Miller KE; Nieminen TT; Comiskey DF; Li W; Brock P; Symer DE; Akagi K; DeLap KE; He H; Koboldt DC; de la Chapelle A
Thyroid; 2019 Jul; 29(7):946-955. PubMed ID: 30957677
[No Abstract] [Full Text] [Related]
20. Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.
Cirello V; Colombo C; Karapanou O; Pogliaghi G; Persani L; Fugazzola L
Front Endocrinol (Lausanne); 2020; 11():589340. PubMed ID: 33488516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
